Oruka Therapeutics, Inc.
(ORKA - NASDAQ)
76,39 USD
📋 Profilo Aziendale

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications.

|